Chaperones as potential therapeutics for Krabbe disease.

about

E-Learning for Rare Diseases: An Example Using Fabry Disease.Heterozygous carriers of galactocerebrosidase mutations that cause Krabbe disease have impaired microglial function and defective repair of myelin damage.

P2860

Q47147113-1B1CEC3C-1246-4505-98D2-00FBEFD286C9 Q52330247-538F8CAE-0D67-46DB-BAD1-FDE7508CC8F8

P2860

Chaperones as potential therapeutics for Krabbe disease.

Item

http://www.wikidata.org/entity/Q38957269

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Chaperones as potential therapeutics for Krabbe disease.

@en

type

Item

label

Chaperones as potential therapeutics for Krabbe disease.

@en

prefLabel

Chaperones as potential therapeutics for Krabbe disease.

@en

P1476

Chaperones as potential therapeutics for Krabbe disease

@en

P2093

Giovanna Pannuzzo

http://www.w3.org/2001/XMLSchema#string

Rosanna Avola

http://www.w3.org/2001/XMLSchema#string

Venera Cardile

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular characterization of mutations that cause globoid cell leukodystrophy and pharmacological rescue using small molecule chemical chaperones

Protein folding and quality control in the ER

Impairment of homeostasis in lysosomal storage disorders

Insights into Krabbe disease from structures of galactocerebrosidase

Structural snapshots illustrate the catalytic cycle of β-galactocerebrosidase, the defective enzyme in Krabbe disease.

Molecular chaperones in the cytosol: from nascent chain to folded protein

Transplantation of umbilical-cord blood in babies with infantile Krabbe's disease

Single-dose intracerebroventricular administration of galactocerebrosidase improves survival in a mouse model of globoid cell leukodystrophy

Molecular genetics of Krabbe disease (globoid cell leukodystrophy): Diagnostic and clinical implications

Autophagy is activated for cell survival after endoplasmic reticulum stress

P304

1220-1230

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JNR.23755

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Adriana Carol Eleonora Graziano

P577

2016-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27638605

http://www.w3.org/2001/XMLSchema#string

P921

molecular chaperones

Chaperones as potential therapeutics for Krabbe disease.

about

P2860

P2860

Chaperones as potential therapeutics for Krabbe disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921